Neoadjuvant Chemotherapy Combined With Targeted Treatment in High-risk Retroperitoneal Sarcoma
Neoadjuvant Chemotherapy Combined With Targeted Treatment in High-risk Retroperitoneal Sarcoma
Enrolling by invitation · NCT05844813 · Registry updated 2023-05-12Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Neoadjuvant Chemotherapy Combined With Targeted Treatment in High-risk Retroperitoneal Sarcoma | retroperitoneal sarcoma | Enrolling by invitation | Phase 4 | 2023-05-12 | NCT05844813 |
7 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Beijing Friendship Hospital | Beijing | China | 4 |
| First Affiliated Hospital Xi'an Jiaotong University | Xi’an | China | 3 |
| Peking University First Hospital | Beijing | China | 41 |
| Shanghai Cancer Hospital, Minhang Branch | Shanghai | China | 1 |
| Shanghai Zhongshan Hospital | Shanghai | China | 4 |
| The Affiliated Hospital of Qingdao University | Qingdao | China | 48 |